Multicentric and contralateral invasive tumors identified with pre-op MRI in patients newly diagnosed with ductal carcinoma in situ of the breast

Breast Journal

Volumn 18, Issue 5, 2012, Pages 420-427

  Hollingsworth, Alan B ^a   Stough, Rebecca G ^b  

^a Mercy Women's Center   (United States)

^b Mercy Health Center   (United States)

Author keywords

contralateral; DCIS; multicentricity; pre op breast MRI

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PARTIAL MASTECTOMY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY;

AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES;

EID: 84866139109     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01273.x     Document Type: Article

References (31)

1. American Cancer Society. Breast Cancer Facts and Figures 2009-2010. Atlanta, GA: American Cancer Society, 2010: p. 4.
2. Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 2010; 102: 161-9.
3. Gonzalez RJ, Buzdar AU, Fraser Symmans W, et al. Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). Breast J 2007; 13: 72-5.
4. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. New Engl J Med 1993; 328: 1581-6.
5. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999; 353: 1993-2000.
6. Dawood S, Broglio K, Gonzalez-Angulo AM, et al. Development of new cancers in patients with DCIS: the M.D. Anderson experience. Ann Surg Oncol 2008; 15: 244-9.
7. Lagios MD, Silverstein MJ,. Ductal carcinoma in situ: through a glass, darkly. Ann Surg Oncol 2008; 15: 16-7.
8. Hollingsworth AB, Stough RG, O'Dell CA, Brekke CE,. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg 2008; 196: 389-97.
9. Guidi AJ, Fischer L, Harris JR, Schnitt SJ,. Microvessel density and distribution in ductal carcinoma in situ of the breast. J Natl Cancer Inst 1994; 86: 614-9.
10. Pengel KE, Loo CE, Teertstra HJ, et al. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 2009; 116: 161-9.
11. Mann RM, Loo CE, Wobbes T, et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 2010; 119: 415-22.
12. Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T,. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009; 198: 262-9.
13. Houssami N, Hayes DF,. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin 2009; 59: 290-302.
14. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, margin status. J Am Coll Surg 2009; 209: 180-7.
15. Turnbull L, Brown S, Harvey I, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomized controlled trial. Lancet 2010; 375: 563-71.
16. Hollingsworth AB, Stough RG,. Conflicting outcomes with preoperative breast MRI: differences in technology or methodology? Breast Dis 2010; 21: 109-12.
17. Peters NH, Borel Rinkes IH, Mali WP, et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome-MONET-study. Trials 2007; 8: 40.
18. Solin LJ, Orel SG, Hwang WT, Harris EE, Schnall MD,. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008; 26: 386-91.
19. Brennan ME, Houssami N, Lord S, et al. Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 2009; 27: 5640-9.
20. Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM,. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease. Cancer 2000; 88: 2739-50.
21. Vuoto HD, García AM, Candás GB, et al. Bilateral breast carcinoma: clinical characteristics and its impact on survival. Breast J 2010; 16: 625-32.
22. Hartman M, Czene K, Reilly M, et al. Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 2006; 25: 4210-6.
23. Morrow M,. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol 2008; 26: 352-3.
24. Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 2010; 28: 4120-8.
25. Sardanelli F, Podo F,. Breast MR imaging in women at high risk of breast cancer. Is something changing in early breast cancer detection?. Eur Radiol 2007; 17: 873-87.
26. Bigenwald RZ, Warner E, Gunasekara A, et al. Is mammography adequate for screening women with inherited BRCA mutations and low breast density? Cancer Epidemiol Biomarkers Prev 2008; 17: 706-11.
27. Gierach GL, Loud JT, Chow CK, et al. Mammographic density does not differ between unaffected BRCA 1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat 2010; 123: 245-55.
28. Adkisson CD, Vallow LA, Kowalchik K, et al. Patient age and preoperative breast MRI in women with breast cancer: biopsy and surgical implications. Ann Surg Oncol 2011; 18: 1678-83. online January 5; e-pub ahead of print.
29. Romero L, Klein L, Ye W, et al. Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 2004; 188: 371-6.
30. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007; 57: 75-89.
31. Taneja C, Edelsberg J, Weycker D, Guo A, Oster G, Weinreb J,. Cost effectiveness of breast screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 2009; 6: 171-9.